ILK and breast carcinoma: ILK phosphorylates GSK3β at Ser9 in breast cancer, affecting the activation of the transcription factor AP1 and the stabilization of β-catenin, which is indirectly related to deregulation of proliferation, migration, and differentiation128,136 (Table 4).